27 results
Plasmacytomas and Plasma-Cell Leukemia - Physical examination revealed multiple exophytic subcutaneous lesions involving the arms and
Plasmacytomas and Plasma-Cell ... revealed 25% plasma cells ... stain) #Clinical #HONC ... Leukemia #Smear #NEJM
Activated T-Cell Killing a Cancer Cell

#TCell #Killing #Cancer #Cells #clinical #microscopy #video
Activated T-Cell ... Killing a Cancer ... #Killing #Cancer ... #Cells #clinical ... #microscopy #video
Activated T-Cell Killing a Cancer Cell

#TCell #Killing #Cancer #Cells #clinical #microscopy #video
Activated T-Cell ... Killing a Cancer ... Cell #TCell #Killing ... #Cancer #Cells ... #clinical #microscopy
Urinary Tract Tuberculosis - Contrast-enhanced computed tomography (CT) of the abdomen showed mild dilatation of the
Urinary Tract Tuberculosis ... the left renal pelvis ... CT #Urogenital #Tuberculosis ... AcidFastBacilli #Microscopy ... #NEJM
Hemolysis in Hereditary Spherocytosis. Panel A shows the structure of a normal red cell and a
of a normal red cell ... spleen in which red cells ... between endothelial cells ... Pathophysiology #Honc ... HereditarySpherocytosis #NEJM
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
ALK-Positive Non–Small-Cell ... Lung Cancer #EBM ... #Honc #Alectinib ... VisualAbstract #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
III Non–Small-Cell ... Lung Cancer - Progression-free ... #EBM #Honc #PACIFIC ... Durvalumab #NSCLC #NEJM
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... macrophages and T cells ... Lymphoma • Lung cancer ... Langerhans giant cells ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... macrophages and T cells ... Lymphoma • Lung cancer ... Langerhans giant cells ... TB #Diagnosis #Management
Acquired von Willebrand Syndrome - Diagnosis and Management
 • Autoantibodies to vWF: Lymphoproliferative disorders (e.g. lymphoma,
Diagnosis and Management ... adsorption onto cancer ... cells (and subsequent ... Syndrome #Diagnosis #Management